[HTML] sciencedirect.com

[HTML][HTML] Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention …

X Calvet, D Carpio, I Rodríguez-Lago… - … y Hepatología (English …, 2021 - Elsevier
Patients with certain immune‐mediated inflammatory diseases, such as rheumatoid arthritis
(RA) and inflammatory bowel disease (IBD), have an increased risk of severe infectious …
被引用次数：8 相关文章

Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention …

X Calvet, D Carpio, I Rodriguez Lago… - … 2021, vol 44, num 8, p …, 2021 - diposit.ub.edu
Patients with certain immune-mediated inflammatory diseases, such as rheumatoid arthritis
(RA) and inflammatory bowel disease (IBD), have an increased risk of severe infectious …

Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention …

X Calvet, D Carpio… - Gastroenterologia …, 2021 - pubmed.ncbi.nlm.nih.gov
Patients with certain immune-mediated inflammatory diseases, such as rheumatoid arthritis
(RA) and inflammatory bowel disease (IBD), have an increased risk of severe infectious …

Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention …

X Calvet, D Carpio, I Rodríguez-Lago… - Gastroenterologia y …, 2021 - europepmc.org
Patients with certain immune-mediated inflammatory diseases, such as rheumatoid arthritis
(RA) and inflammatory bowel disease (IBD), have an increased risk of severe infectious …